MSMaya Schwartz

Maya Schwartz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maya Schwartz has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Microcirculatory Collaterals Modulate Ischemic Core Heterogeneity on Diffusion-Weighted Imaging

    by Aroosa Zamarud, Michael Mlynash, Nicole Yuen, Henk van Voorst, Adrien ter Schiphorst, Pierre Seners, Anke Wouters, Maya Schwartz, Greg W. Albers, Bruce Campbell, et al.

    Endovascular thrombectomy (EVT) is an effective treatment for acute ischemic stroke due to large vessel occlusion (AIS-LVO). The ischemic core is best determined on DWI, which is commonly thresholded for automated analysis using ADC maps. However, there may be substantial heterogeneity in ADC values within the ischemic core. We determined how tissue-level collaterals, measured by hypoperfusion intensity ratio (HIR) on cerebral perfusion imaging, influences ischemic core heterogeneity. We performed a post hoc analysis of the CT Perfusion to Predict Response to Recanalization in Ischemic Stroke Project 2 (CRISP 2) study of patients with AIS-LVO who underwent baseline CT/CTP and follow-up MRI/MR perfusion (MRP) prior to EVT. Patients were dichotomized into favorable (HIR ≤0.5) and unfavorable (HIR >0.5) groups, and variability in ADC reduction was determined across an ischemic core defined by standard thresholds of ADC ≤620 × 10-6 mm²/s. One hundred ninety-seven CRISP 2 patients met criteria: 113 (57%) favorable HIR and 84 (43%) unfavorable HIR. Favorable HIR patients had lower baseline NIHSS scores (median 14 versus 16; P = .012), smaller hypoperfusion volumes (time-to-maximum >6 seconds and >10 seconds), smaller ischemic core volumes (27 mL versus 50 mL; P < .001), and were less frequently treated with IV thrombolysis (29% versus 45%; P = .016). ADC heterogeneity was lower in favorable HIR (standard deviation: 167.2 versus 193.5; P = .01), but the mean ADC was similar between groups. Clinical outcomes were not different between favorable and unfavorable HIR groups. Multivariable analysis showed HIR was independently associated with ADC standard deviation (P = .002) and coefficient of variation (P = .003) at the comprehensive stroke center. Favorable tissue-level collaterals (low HIR) are associated with reduced ischemic core ADC heterogeneity.

  • Association Between Venous Transit and Functional Outcomes Post Thrombectomy in Patients with Acute Basilar Artery Occlusion

    by Maya Schwartz, Michael Mlynash, Vivek Yedavalli, Nicole Yuen, Rahul Karamchandani, Maarten G. Lansberg, Gregory W. Albers, Jeremy J. Heit

    Prolonged venous transit (PVT) is an imaging marker that assesses venous outflow (VO) on perfusion imaging time to maximum (Tmax) maps. PVT presence (PVT+) is associated with 90-day mortality and poor functional recovery in patients with anterior circulation acute ischemic stroke caused by large vessel occlusion (AIS-LVO) who underwent endovascular thrombectomy (EVT). PVT absence (PVT-) correlates with excellent outcomes. We determined the association between PVT and functional outcomes post-EVT in patients with acute basilar artery occlusions (BAO). In this retrospective study, we included patients from nine academic medical centers. We selected patients who had pre-thrombectomy CT or MR perfusion imaging and assessment of 90-day Modified Rankin Scale (mRS). PVT+ in the posterior circulation was defined as a Tmax≥10 seconds delay in the torcula, left transverse sinus, and/or right transverse sinus. PVT- was defined as the absence of this marker. The primary outcome was excellent functional outcome at 90 days as defined by an mRS 0-1. Ninety-seven patients with acute BAO were scored for PVT. 58 patients (60%) had PVT+ and 39 (40%) had PVT-. PVT- patients were younger (median age 60 years [IQR 50-70] versus 68 years [IQR 62-79] in PVT+; p=0.01), more likely to present with a wake-up stroke (44% versus 16% in PVT+; p=0.04), and more likely to have excellent functional outcomes (44% versus 22% in PVT+; p=0.03). In an adjusted multivariable regression analysis, lower presentation NIHSS was associated with excellent functional outcomes (OR: 0.89; 95% CI: 0.82-0.96, p=0.002). There was also a significant interaction between age and PVT, where older patients with PVT+ experienced worse outcomes (p=0.04). In patients with acute BAO who underwent EVT, lower presentation NIHSS was associated with excellent 90-day functional outcomes, and PVT+ was associated with worse outcomes in older patients.

  • Association of Good Venous Outflow with Favorable Outcomes in Patients with Acute Ischemic Stroke Caused by Large Vessel Occlusion Treated with Multiple Endovascular Thrombectomy Passes

    by Maya A. Schwartz, Michael Mlynash, Tobias D. Faizy, Pierre Seners, Anke Wouters, Nicole Yuen, Jamie Kesten, Aroosa Zamarud, Jens Fiehler, Maarten G. Lansberg, et al.

    Endovascular thrombectomy (EVT) is an effective treatment of acute ischemic stroke caused by large-vessel occlusion (AIS-LVO) of the anterior circulation, and technical success is essential to maximize outcomes. Increased EVT pass counts have been associated with reduced procedural efficacy and worse patient outcomes. We examined the impact of pre-EVT cerebral perfusion imaging parameters on clinical outcomes in patients with high EVT pass numbers. We performed a multicenter retrospective analysis of patients with AIS-LVO who had pretreatment CTA and CTP imaging and a pass count ≥3. Baseline NCCT imaging was analyzed according to ASPECTS. Ischemic core was defined as relative CBF 10 seconds/>6-second volumetric ratio) on CTP, and venous outflow (VO) on CTA. The primary outcome was favorable clinical outcomes (mRS 0-2) at 90 days. One hundred seventy-eight patients met the inclusion criteria and were dichotomized into favorable (mRS 0-2, 29%) and unfavorable outcome (mRS 3-6, 71%) groups. Patients with favorable outcomes had lower blood glucose levels (mean, 115 mg/dL; interquartile range [IQR], 102-128 versus 126 mg/dL [IQR, 103-156; P = .03) and lower baseline NIHSS scores (median, 9; IQR, 6.5-13.5 versus 17; IQR, 13-20; P < .001) compared with those with unfavorable outcomes. On pre-EVT imaging, favorable patients had smaller ischemic core volumes (median, 2 mL; IQR, 0-14 versus 16 mL; IQR, 0-39; P < .001), higher ASPECTS (median, 9; IQR, 7-10 versus 7; IQR, 6-9; P = .001), a higher frequency of favorable CTA collaterals (87% versus 57%, P < .001), a more favorable hypoperfusion intensity ratio (median, 0.3; IQR, 0.2-0.5 versus 0.5; IQR, 0.4-0.6; P < .001), and higher rates of favorable VO (73% versus 15%; P < .001). In a regression analysis, favorable outcome was independently associated with lower-presentation NIHSS (OR, 0.84; 95% CI, 0.76-0.93; P < .001), successful reperfusion (modified TICI score 2b-3; OR, 4.95; 95% CI, 1.18-20.72; P = .03), and favorable VO (OR, 12.35; 95% CI, 4.23-36.10; P < .001). In Patients with AIS-LVO treated with EVT that involved ≥3 passes, lower presentation NIHSS, successful reperfusion, and favorable VO were associated with an increased likelihood of a favorable outcome.

  • Effectiveness and Safety of IV Thrombolysis Before Hospital Transfer for Thrombectomy in Patients With Basilar Artery Occlusion

    by Simon Liebart, Maarten G. Lansberg, Grace Adwane, Frédérique Charbonneau, Maya Schwartz, Jeremy J. Heit, Michael Mlynash, Denis Sablot, Anne Wacongne, Jean-Philippe Desilles, et al.

    The benefit of IV thrombolysis (IVT) before endovascular therapy (EVT) in acute ischemic stroke patients with basilar artery occlusion (BAO) remains unclear. Most existing studies have focused on patients directly admitted to comprehensive stroke centers (CSCs), where EVT is readily available. Our objective was to evaluate the effectiveness and safety of IVT initiated before interhospital transfer in patients with BAO initially admitted to a primary stroke center (PSC). We analyzed data from 3 prospectively collected cohorts of patients with BAO transferred from a PSC to a CSC (Rothschild Foundation Hospital, Montpellier University Hospital, Stanford Hospital) for EVT consideration, regardless of whether EVT was ultimately performed. The primary effectiveness outcome was favorable 3-month functional outcome (modified Rankin Scale [mRS] score 0-2). Secondary effectiveness outcomes included excellent outcome (mRS score 0-1) and basilar artery recanalization during transfer (modified Thrombolysis In Cerebral Infarction score 2a-3 at CSC arrival). Safety outcomes included 3-month mortality and any intracerebral hemorrhage (ICH) on 24-hour imaging. The relationship between outcomes and IVT was assessed using multivariable logistic regression adjusting for relevant confounders. A total of 230 patients were included (median age, 71 years [interquartile range (IQR) 60-78]; 47% female). Ninety (39%) received IVT before transfer. IVT was mostly withheld because of presentation beyond 4.5 hours (61%) or anticoagulant use (14%). The median NIHSS score at the PSC was 14 (IQR 7-24). In multivariable analyses adjusted for the main confounders, IVT was independently associated with favorable 3-month outcome (39% vs 24%, adjusted odds ratio [aOR] 2.02, 95% CI 1.03-3.97, p = 0.04). Regarding secondary outcomes, IVT was associated with basilar recanalization during transfer (aOR 23.7, 95% CI 6.9-81.3, p < 0.001) while mortality at 90 days (aOR 1.12, 95% CI 0.58-2.18) and any ICH at 24 hours (aOR 1.55, 95% CI 0.77-3.1) did not significantly differ between IVT-treated and non-IVT-treated patients. In patients with BAO transferred for thrombectomy consideration, IVT before transfer was associated with improved recanalization and functional outcomes, without significant safety concerns. However, IVT was administered in only 39% of patients, suggesting a potential need to broaden IVT eligibility criteria in this setting. These findings require confirmation in future studies, given the limited sample size and observational design. This study provides Class III evidence that in patients with BAO, administering IVT before hospital transfer for thrombectomy is safe and associated with a favorable functional outcome at 3 months.